Epkinri subcutaneous injection 48mg, manufactured by Genmab, contains Epcoritamab (genetical recombination). This bispecific antibody facilitates T-cell-mediated cytotoxicity against malignant B-cells by simultaneously binding to CD20 on B-cells and CD3 on T-cells. It is supplied as 48mg in 0.8mL per bottle, with YJ code 4291469A2024.
Epkinri subcutaneous injection 48mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →